realme launches two 4G flagship smartphones in India
by Maria Thomas
Updated Jun 25, 2020
realme X3 SuperZoom with 5X periscope telephoto lens that supports up to 60X hybrid zoom will be available in two variants: 8GB+128GB for Rs 27,999 and 12GB+256GB for Rs 32,999.
realmeX3 that comes with a 2Xtelephoto lens promising up to 20X hybrid zoom will also be available in two variants: 8GB+128GB for Rs 25,999 and 6GB +128GB from Rs 24,999.
realme X3 and X3 SuperZoom will be available in two colours – Glacier Blue and Arctic White - on realme.com and Flipkart starting June 30, announced the company.
Both the devices are packed with 7nm Qualcomm Snapdragon 855+, 64MP quad-camera, 4200mAh battery with 30W Dart charge along with and 120Hz dual punch-hole display.
"To further strengthen our relationship with customers, we have launched our best 4G flagship series, the realme X3 & X3 SuperZoom along with realme Buds Q and realme Adventurer Backpack," said MadhavSheth, Vice President, realme and Chief Executive Officer, realme India.
Both the devices have dual, in-display ultra-wide-angle camera setup at the front.
X3 SuperZoom houses an attached 32MP Sony wide-angle main camera with 8MP super wide-angle camera, while for realme X3, a 16MP Sony wide-angle main camera along with 8MP super wide-angle camera has been offered.
While realme Buds Q is priced at Rs 1,999 and would be available from July 1, the ‘Adventurer Backpack' will cost Rs 1,499 and would be available from the same date.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report